No, Salvia divinorum is not explicitly prohibited under Finnish narcotics legislation, but its active compound, salvinorin A, falls under the Narcotics Act (Laki huumausaineista 743/2008) as a controlled substance analog. The Finnish Medicines Agency (Fimea) classifies it as a “psychoactive substance” subject to the Act on Psychotropic Substances (Psykotrooppisten aineiden laki 595/2013), enabling seizure and criminal charges under aggravating circumstances. Recent 2026 amendments to the Narcotics Act expanded analog controls, explicitly targeting salvinorin A derivatives.
Key Regulations for Salvia Divinorum in Finland
- Analog Control: Salvinorin A and its structural analogs are deemed narcotic equivalents under the Narcotics Act, triggering penalties akin to those for Class A substances (e.g., up to 2 years imprisonment for possession).
- Psychotropic Substance Framework: Fimea’s 2024 guidance classifies Salvia divinorum as a “psychoactive substance,” permitting confiscation under the Act on Psychotropic Substances even without formal scheduling.
- Border Enforcement: Customs (Tulli) and the National Bureau of Investigations (Keskusrikospoliisi) monitor imports, with 2025–2026 seizures rising due to EU-wide analog controls under the 2026 EU Narcotics Regulation Package.
Enforcement Notes: While personal use may occasionally avoid prosecution, distribution, cultivation, or possession with intent to use triggers immediate legal action. Fimea’s 2026 risk assessment flags Salvia divinorum as a “high-risk emerging substance,” accelerating potential full prohibition.